[1] HU J Y,HAN J,CHU Z G,et al.Astragaloside Ⅳ attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels[J].Clin Exp Pharmacol Physiol,2009,36(4):351-357.
[2] 关凤英,李红,杨世杰.黄芪甲苷诱导NO生成并激活PKCε对大鼠心肌缺血再灌注损伤的保护作用[J].吉林大学学报:医学版,2010,36(2):340-344.
[3] ZHANG W D,CHEN H,ZHANG C,et al.Astragaloside Ⅳ from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro[J].Planta Med,2006,72(1):4-8.
[4] 胡炯宇,黄跃生,张琼,等.黄芪甲苷减轻缺氧心肌细胞氧化损伤的机制研究[J].中国烧伤杂志,2007,23(3):175-178.
[5] LI Z P,CAO Q.Effects of astragaloside Ⅳ on myocardial calcium transport and cardiac function in ischemic rats[J].Acta Pharmacol Sin,2002,23(10):898-904.
[6] XU X L,CHEN X J,JI H,et al.Astragaloside Ⅳ improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase[J].Pharmacology,2008,81(4):325-332.
[7] 夏之宁,庞媛,郑国灿.基于毛细管电泳的黄芪抗氧化生物指纹图谱研究[J].分析化学,2008,36(12):1646-1650.
[8] 承燕,江时森.黄芪甲苷对心血管保护功能的研究进展[J].医学研究生学报,2011,24(6):637-640.
[9] 杨国富,刘革新,董果雄,等.黄芪甲苷对缺氧/复氧损伤人脐静脉内皮细胞与中性粒细胞黏附能力及细胞核转录因子κb表达的影响[J].中国组织工程研究与临床康复,2008,12(15):2843-2846. |